RHON-KLINIKUM AG, one of Germany's largest healthcare providers, reported a stable business performance for the first half of 2026, with consolidated revenue reaching EUR 863.6 million, a slight increase from EUR 833.5 million in the same period last year. EBITDA rose to EUR 57.0 million from EUR 46.7 million, and consolidated profit improved to EUR 22.5 million from EUR 14.7 million. The company treated 513,700 patients on an outpatient and inpatient basis, a 9% increase year-over-year.
These results were partly impacted by immediate transformation costs established to offset higher personnel and material costs from previous years. The company continues to invest in expanding regional health networks and modernizing medical technology across its sites. In Hesse, Universitatsklinikum Marburg and Lungenfachklinik Immenhausen have formed a strategic partnership to improve lung patient care. In Brandenburg, a new child protection emergency service at the Frankfurt (Oder) site, along with cooperation agreements with the city and district, strengthens the regional network for child and adolescent care.
Dr. Gunther K. WeiB, member of the Board of Management, emphasized the importance of regional networks: "Regional networks form a vital and essential part of any future healthcare system. Rigid sectoral boundaries make it more difficult to provide patients with the care they need and saddle our healthcare system with unnecessary costs. It is only when general practitioners, specialists, medical facilities, nurses and therapists work together as a team that we can pool our resources efficiently."
However, the company faces significant challenges from recent legislative changes. Dr. Stefan Stranz, also on the Board of Management, criticized the Statutory Health Insurance Contribution Rate Stabilization Act, stating it "imposes further burdens on hospitals. Instead of reducing bureaucracy and refocusing on patient care, the reform saddles already overburdened hospitals with even more documentation requirements, excessive budget cuts, and financial risks."
For the full year 2026, RHON-KLINIKUM expects revenues of around EUR 1.7 billion (plus or minus 5%) and EBITDA between EUR 110 million and EUR 125 million. The company also anticipates moderate improvements in non-financial indicators like number of cases and cost weights.
The financial year will be significantly influenced by the ongoing legislative process, particularly the Hospital Reform Adjustment Act (KHAG) and the GKV-BStabG. These reforms aim to enhance quality and efficiency but may increase financial pressure on hospitals in the short term. The company acknowledges that its forecast is subject to uncertainties due to regulatory changes, global crises, and economic volatility.
For more details, the full interim report is available on the company's website at RHON-KLINIKUM AG.
